世界の小動物画像撮像解析市場...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
1.5.5 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.2.1 SMALL ANIMAL IMAGING (IN VIVO) MARKET, BY TECHNOLOGY
3.2.2 SMALL ANIMAL IMAGING (IN VIVO) MARKET, BY REAGENTS
3.3 MARKET DYNAMICS
3.3.1 DRIVERS
3.3.1.1 TECHNOLOGICAL ADVANCEMENTS
3.3.1.2 GROWING ADOPTION RATE FOR SMALL ANIMAL IMAGING
3.3.1.3 RISING APPLICATION OF FUNCTIONAL IMAGING
3.3.1.4 INCREASING NUMBER OF PHARMA COMPANIES AND RESEARCH INSTITUTIONS
3.3.2 RESTRAINTS
3.3.2.1 HIGH DEVICE COST
3.3.2.2 TECHNOLOGICAL LIMITATIONS
3.3.2.3 HIGH COST AND DATA REQUIREMENTS FOR BRINGING NEW TECHNOLOGY
3.3.3 OPPORTUNITIES
3.3.3.1 NEXT UNIQUE COMBINATIONS IN MRI
3.3.3.2 HIGH RESOLUTION & SENSITIVITY OF IMAGING DEVICES WITH USAGE IN MULTIPLE APPLICATIONS
3.3.3.3 EMERGING MARKETS
3.3.4 CHALLENGES
3.3.4.1 SUSTAINABILITY OF PLAYERS IN HIGHLY COMPETITIVE MARKET
3.3.4.2 AVAILABILITY OF RADIOPHARMACEUTICALS
3.4 MARKET SHARE ANALYSIS
3.4.1 BY TECHNOLOGY
3.4.2 BY MARKET PLAYERS
3.4.3 BY GEOGRAPHY

4 GLOBAL SMALL ANIMAL IMAGING (IN VIVO) SYSTEMS MARKET, BY TECHNOLOGY
4.1 INTRODUCTION
4.2 STANDALONE TECHNOLOGY FOR SMALL ANIMAL IMAGING (IN VIVO)
4.2.1 NUCLEAR IMAGING
4.2.1.1 MICRO-SPECT
4.2.1.2 MICRO-PET
4.2.2 OPTICAL IMAGING
4.2.2.1 FLUORESCENCE
4.2.2.2 BIOLUMINESCENCE
4.2.2.3 NEAR INFRARED FLUORESCENCE
4.2.3 MICRO-MRI
4.2.4 MICRO-CT
4.2.5 MICRO-ULTRASOUND
4.3 MULTIMODAL IMAGING FOR SMALL ANIMAL IMAGING (IN VIVO)
4.3.1 MULTIMODAL NUCLEAR IMAGING DEVICES
4.3.1.1 SPECT + CT
4.3.1.2 SPECT + MR
4.3.1.3 PET + CT
4.3.1.4 PET + MR
4.3.1.5 SPECT + PET + CT
4.3.2 MULTIMODAL OPTICAL IMAGING DEVICES
4.3.2.1 OPTICAL+ X-RAY + RADIOISOTOPIC

5 GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET, BY REAGENTS
5.1 INTRODUCTION
5.2 NUCLEAR IMAGING FOR SMALL ANIMAL IMAGING (IN VIVO)
5.2.1 PET TRACERS
5.2.1.1 FLUORINE-18 BASED
5.2.1.2 CARBON-11 BASED
5.2.1.3 COPPER-64 BASED
5.2.1.4 OTHERS
5.2.2 SPECT PROBES
5.2.2.1 TECHNETIUM-99M BASED
5.2.2.2 IODINE-131 BASED
5.2.2.3 GALLIUM-67 BASED
5.2.2.4 THALLIUM-201 BASED
5.2.2.5 OTHERS
5.3 OPTICAL IMAGING FOR SMALL ANIMAL IMAGING (IN VIVO)
5.3.1 BIOLUMINESCENCE
5.3.1.1 LUCIFERINS
5.3.1.2 PROLUCIFERINS
5.3.1.3 COELENTERAZINE
5.3.1.4 OTHERS
5.3.2 FLUORESCENCE
5.3.2.1 GREEN FLUORESCENT PROTEINS
5.3.2.2 RED FLUORESCENT PROTEINS
5.3.2.3 INFRARED DYES
5.3.2.4 OTHERS (NATURAL FLUORESCENCE MOLECULES SUCH AS COLLAGEN AND ELASTIN)
5.4 MRI CONTRAST REAGENTS FOR SMALL ANIMAL IMAGING (IN VIVO)
5.4.1 GADOLINIUM BASED
5.4.2 IRON BASED
5.5 CT CONTRAST REAGENTS FOR SMALL ANIMAL IMAGING (IN VIVO)
5.5.1 IODINE BASED
5.5.2 BARIUM BASED
5.5.3 GASTROGRAFIN BASED
5.6 ULTRASOUND CONTRAST REAGENTS FOR SMALL ANIMAL IMAGING (IN VIVO)
5.6.1 GADOLINIUM OXIDE ALBUMIN MICROSPHERES – GOAM

6 GEOGRAPHIC ANALYSIS
6.1 INTRODUCTION
6.2 NORTH AMERICA
6.3 EUROPE
6.4 ASIA-PACIFIC
6.5 REST OF THE WORLD (ROW)

7 COMPETITIVE LANDSCAPE
7.1 INTRODUCTION

8 COMPANY PROFILES (Overview, Financials, Products & Services, Strategy, & Developments)*
8.1 AGILENT TECHNOLOGIES, INC.
8.2 ASPECT IMAGING
8.3 BIOSCAN, INC.
8.4 BRUKER CORPORATION
8.5 FUJIFILM HOLDINGS CORPORATION
8.6 GAMMA MEDICA-IDEAS, INC.
8.7 GENOVIS AB
8.8 LI-COR BIOSCIENCES
8.9 LIFE TECHNOLOGIES CORPORATION
8.10 MEDISO MEDICAL IMAGING SYSTEMS
8.11 MILTENYI BIOTEC GMBH
8.12 PERKINELMER, INC.
8.13 PROMEGA CORPORATION
8.14 SCANCO MEDICAL AG
8.15 SIEMENS AG
8.16 SOFIE BIOSCIENCES, INC.
8.17 TARGESON, INC.
8.18 UVP, LLC.
*Details On Financials, Product & Services, Strategy, And Developments Might Not Be Captured In Case Of Unlisted Companies.